+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Lyophilization Services Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Biologic Lyophilized, Type of Primary Packaging System, and Key Geographies

  • PDF Icon

    Report

  • 225 Pages
  • April 2025
  • Region: Global
  • Roots Analysis
  • ID: 5578615

The global lyophilization services market is estimated to grow from USD 2.6 billion in 2025 to USD 4.9 billion by 2035, at a CAGR of 6.3% during the forecast period to 2035.

Lyophilization Services Market: Growth and Trends

Lyophilization is a drug stabilization technique that involves removing excess solvents, such as water, through freeze-drying while preserving the chemical properties of the substance. Notably, lyophilization utilizes specialized equipment, including laboratory freeze dryers, non-sterile freeze dryers, and sterilizable lyophilizers. It is worth highlighting that over the years, lyophilization has emerged as the preferred approach to achieve longer and commercially viable shelf lives, enabling stable and dry biopharmaceutical formulations. However, characterized by a rapidly growing pipeline of biosimilars and novel biologics, and the existing challenges associated with lyophilization of biotherapeutics, stakeholders are increasingly relying on service providers that offer multidisciplinary expertise in this domain.

In addition, several market leaders are accelerating their research for lyophilization technology advancements and innovations to improve working efficiency and achieve process control during the drying process. This has resulted in improved productivity and efficiency of the overall process.  For instance, latest technologies, such as continuous freeze-drying systems and automated lyophilization systems, are encouraging industrial leaders to adopt these technologies and meet the customized lyophilization services requirements of clients.

Lyophilization Services Market: Key Insights

The report delves into the current state of the lyophilization services market and identifies potential growth opportunities within industry.

Some key findings from the report include:

  • Presently, over 105 service providers claim to have the required expertise to offer lyophilization services for a variety of biotherapeutics, including proteins, antibodies, nucleic acids and cell / gene therapies.
  • The current market landscape is highly fragmented, featuring the presence of both new entrants and established players based in key geographical regions.
  • Leveraging their expertise, stakeholders are offering lyophilization services at different scales of operation; further, vials emerged as the preferred choice of primary packaging system for storing biologics.

  • In order to successfully navigate the evolving regulatory landscape, service providers are expanding their portfolios to cater to customized requests of their clients.
  • The growing interest in this domain is evident from the rise in partnership activity; in fact, the maximum number of collaborations related to lyophilization of biopharmaceuticals were signed in the past two years.
  • To keep pace with the growing demand, many companies have undertaken expansion initiatives, such as establishing new facilities or expanding their existing capabilities, to strengthen their service portfolio.
  • The market is expected to grow at a steady rate till 2035; the projected opportunity is anticipated to be well distributed across various types of biologic lyophilized, primary packaging systems and geographical regions.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Biologic Lyophilized

  • Antibodies
  • Cells and Gene Therapies
  • Vaccines
  • Other Biologics

Type of Primary Packaging System

  • Vials
  • Syringes
  • Cartridges
  • Ampoules
  • Others

Key Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and North Africa

Lyophilization Services Market: Key Segments

Antibodies Segment holds the Largest Share of the Lyophilization Services Market

Based on the type of biologics lyophilized, the market is segmented into antibodies, cell and gene therapies, vaccines, and other biologics. At present, the antibodies segment holds the maximum share of the global lyophilization services market. This trend is likely to remain the same in the coming years owing to the increasing demand for target-specific drugs for the treatment of a myriad of diseases.

By Type of Primary Packaging System, Syringes is the Fastest Growing Segment of the Global Lyophilization Services Market

Based on the type of primary packaging system, the market is segmented into vials, syringes, cartridges, ampoules, and others. At present, the vials segment holds the maximum share of the global lyophilization services market. However, the market for syringes segment is expected to grow at a higher CAGR during the forecast period owing to the growing demand for automated drug delivery injections and prefilled syringes.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa and Latin America. Currently, North America dominates the global lyophilization services market and accounts for the largest revenue share. Further, the market in Asia-Pacific is likely to grow at a higher CAGR in the coming future.

Example Players in the Lyophilization Services Market Include:

  • Baxter BioPharma Solutions
  • CordenPharma
  • Coriolis Pharma
  • Curia
  • Emergent BioSolutions
  • LSNE Contract Manufacturing
  • Lyophilization Technology
  • Northway Biotech
  • ProJect Pharmaceutics
  • Vetter Pharma

Lyophilization Services Market: Research Coverage

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global lyophilization services market, focusing on key market segments, including type of biologic lyophilized, type of primary packaging system and key geographies.
  • Market Landscape: A comprehensive evaluation of the companies offering lyophilization services, based on several relevant parameters, such as year of establishment, company size, location of headquarters, the scale of operation,  regulatory certification / accreditation, type of biologic lyophilized, the process of lyophilization, type of primary packaging system and additional services offered by the firms.
  • Benchmark Analysis: A comprehensive benchmark analysis of various service providers segregated into three peer groups based on the location of their headquarters. Additionally, the companies were further distributed across key geographies, based on their employee count, into three categories, namely small, mid-sized and large / very large, highlighting the top players in the lyophilization services market, based on their respective capabilities.
  • Company Profiles: In-depth profiles of key players that are currently engaged in offering lyophilization services for biopharmaceuticals, focusing on overview of the company, lyophilization service offerings for biopharmaceuticals, dedicated facilities and recent developments and an informed future outlook.
  • Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in this domain, based on several parameters, such as year of partnership, type of partnership, most active players (in terms of the number of partnerships signed) and geographical distribution.
  • Recent Expansions: In-depth analysis of the various expansion initiatives undertaken by lyophilization service providers for biopharmaceuticals, based on several parameters, such as year of expansion, type of expansion, company size,  location of headquarters, location of expanded facility, most active players (in terms of number of recent expansions) and geographical distribution.
  • Survey Analysis: An insightful analysis presenting additional insights on lyophilization services offered for biopharmaceuticals, based on several parameters, such as type of biologic lyophilized, type of primary packaging system, scale of operation, availability of lyophilization cycle development / optimization capabilities and location of a dedicated manufacturing facility for lyophilization.
  • Case Study 1: A detailed discussion on lyophilization cycle development and optimization services, highlighting the important parameters and techniques required for these processes.
  • Case Study 2: A comprehensive discussion on the alternative approaches to the lyophilization process, such as spray drying, spray freeze dryer, atmospheric spray freeze dryer, and vacuum foam drying.

Key Questions Answered in this Report

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

Additional Benefits

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Lyophilization
3.2.1. Historical Evolution
3.2.2. Underlying Principles
3.2.3. Advantages and Disadvantages
3.3. Lyophilization of Biopharmaceuticals
3.3.1. Need for Lyophilization of Biopharmaceuticals
3.3.2. Lyophilization Process
3.3.2.1. Formulation and Filling
3.3.2.2. Freezing
3.3.2.3. Primary Drying
3.3.2.4. Secondary Drying
3.4. Lyophilizer and its Key Components
3.5. Primary Packaging Systems Used for Lyophilization of Biopharmaceuticals
3.6. Lyophilization Cycle Development and Optimization
3.7. Concluding Remarks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Lyophilization Service Providers for Biopharmaceuticals: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Scale of Operation
4.2.5. Analysis by Regulatory Certification / Accreditation
4.2.6. Analysis by Type of Biologic Lyophilized
4.2.7. Analysis by Process of Lyophilization
4.2.8. Analysis by Type of Primary Packaging System
4.2.9. Analysis by Additional Services Offered

5. BENCHMARK ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Benchmark Analysis: Peer Groups
5.3.1. Benchmark Analysis: North America (Peer Group I)
5.3.2. Benchmark Analysis: North America (Peer Group II)
5.3.3. Benchmark Analysis: North America (Peer Group III)
5.3.4. Benchmark Analysis: Europe (Peer Group IV)
5.3.5. Benchmark Analysis: Europe (Peer Group V)
5.3.6. Benchmark Analysis: Europe (Peer Group VI)
5.3.7. Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VII)
5.3.8. Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VIII)

6. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN NORTH AMERICA
6.1. Chapter Overview
6.2. Baxter BioPharma Solutions
6.2.1. Company Overview
6.2.2. Lyophilization Service Offerings for Biopharmaceuticals
6.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
6.2.4. Recent Developments and Future Outlook
6.3. Curia
6.3.1. Company Overview
6.3.2. Lyophilization Service Offerings for Biopharmaceuticals
6.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
6.3.4. Recent Developments and Future Outlook
6.4. Emergent BioSolutions
6.4.1. Company Overview
6.4.2. Lyophilization Service Offerings for Biopharmaceuticals
6.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
6.4.4. Recent Developments and Future Outlook
6.5. LSNE Contract Manufacturing
6.5.1. Company Overview
6.5.2. Lyophilization Service Offerings for Biopharmaceuticals
6.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
6.5.4. Recent Developments and Future Outlook
6.6. Lyophilization Technology
6.6.1. Company Overview
6.6.2. Lyophilization Service Offerings for Biopharmaceuticals
6.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
6.6.4. Recent Developments and Future Outlook

7. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN EUROPE
7.1. Chapter Overview
7.2. CordenPharma
7.2.1. Company Overview
7.2.2. Lyophilization Service Offerings for Biopharmaceuticals
7.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
7.2.4. Recent Developments and Future Outlook
7.3. Coriolis Pharma
7.3.1. Company Overview
7.3.2. Lyophilization Service Offerings for Biopharmaceuticals
7.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
7.3.4. Recent Developments and Future Outlook
7.4. Northway Biotech
7.4.1. Company Overview
7.4.2. Lyophilization Service Offerings for Biopharmaceuticals
7.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
7.4.4. Recent Developments and Future Outlook
7.5. ProJect Pharmaceutics
7.5.1. Company Overview
7.5.2. Lyophilization Service Offerings for Biopharmaceuticals
7.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
7.5.4. Recent Developments and Future Outlook
7.6. Vetter Pharma
7.6.1. Company Overview
7.6.2. Lyophilization Service Offerings for Biopharmaceuticals
7.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
7.6.4. Recent Developments and Future Outlook

8. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN ASIA PACIFIC
8.1. Chapter Overview
8.2. BioZed Engineering
8.2.1. Company Overview
8.2.2. Lyophilization Service Offerings for Biopharmaceuticals
8.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
8.2.4. Recent Developments and Future Outlook
8.3. CinnaGen
8.3.1. Company Overview
8.3.2. Lyophilization Service Offerings for Biopharmaceuticals
8.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
8.3.4. Recent Developments and Future Outlook
8.4. MabPlex
8.4.1. Company Overview
8.4.2. Lyophilization Service Offerings for Biopharmaceuticals
8.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
8.4.4. Recent Developments and Future Outlook
8.5. Samsung Biologics
8.5.1. Company Overview
8.5.2. Lyophilization Service Offerings for Biopharmaceuticals
8.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
8.5.4. Recent Developments and Future Outlook
8.6. WuXi Biologics
8.6.1. Company Overview
8.6.2. Lyophilization Service Offerings for Biopharmaceuticals
8.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
8.6.4. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Lyophilization Services for Biopharmaceuticals: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Most Active Players: Analysis by Number of Partnerships
9.3.5. Analysis by Geography
9.3.5.1. Intercontinental and Intracontinental Deals
9.3.5.2. International and Local Deals

10. RECENT EXPANSIONS
10.1. Chapter Overview
10.2. Lyophilization Services Market for Biopharmaceuticals: List of Recent Expansions
10.2.1. Analysis by Year of Expansion
10.2.2. Analysis by Type of Expansion
10.2.3. Analysis by Year and Type of Expansion
10.2.4. Analysis by Company Size and Location of Headquarters
10.2.5. Analysis by Location of Expanded Facility
10.2.6. Active Players: Analysis by Number of Recent Expansions
10.2.7. Analysis by Geography

11. SURVEY ANALYSIS
11.1. Chapter Overview
11.2. Lyophilization Services Market for Biopharmaceuticals: List of Participating Companies
11.2.1. Analysis by Seniority Level of Respondents
11.2.2. Analysis by Type of Biologic Lyophilized
11.2.3. Analysis by Type of Primary Packaging System
11.2.4. Analysis by Scale of Operation
11.2.5. Analysis by Additional Services Offered
11.2.6. Analysis by Location of Lyophilization Facility
11.2.7. Analysis by Share of Lyophilization Operations Outsourced
11.2.8. Analysis by Likely Market Size
11.2.9. Analysis of Likely Market Share by Type of Biologic Lyophilized
11.2.10. Analysis of Likely Market Share by Geography

12. CASE STUDY I: LYOPHILIZATION CYCLE DEVELOPMENT AND OPTIMIZATION
12.1. Chapter Overview
12.2. Lyophilization Cycle Development
12.3. Lyophilization Cycle Optimization
12.4. Lyophilization Cycle Development and Optimization: List of Service Providers
12.4.1. Analysis by Company Size
12.4.2. Analysis by Location of Headquarters
12.4.3. Analysis by Type of Service Offered
12.4.4. Lyophilization Cycle Development and Optimization Service Providers: Company Snapshots

13. CASE STUDY II: ALTERNATIVE APPROACHES TO LYOPHILIZATION
13.1. Chapter Overview
13.2. Alternative Approaches to Lyophilization
13.2.1. Spray Drying
13.2.1.1. Spray Drying Process
13.2.1.2. Applications of Spray Drying
13.2.1.3. Spray Drying of Biopharmaceuticals
13.2.1.4. Spray Drying Service Providers for Biopharmaceuticals
13.2.1.5. Comparison of Lyophilization and Spray Drying
13.2.2. Spray Freeze Drying
13.2.3. Atmospheric Spray Freeze Drying
13.2.4. Vacuum Foam Drying

14. MARKET FORECAST AND OPPORTUNITY ANALYSIS
14.1. Chapter Overview
14.2. Forecast Methodology and Key Assumptions
14.3. Global Lyophilization Services Market for Biopharmaceuticals, 2022-2035
14.4. Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized, 2022 and 2035
14.4.1. Lyophilization Services Market for Antibodies, 2022-2035
14.4.2. Lyophilization Services Market for Cell and Gene Therapies, 2022-2035
14.4.3. Lyophilization Services Market for Vaccines, 2022-2035
14.4.4. Lyophilization Services Market for Other Biologics, 2022-2035
14.5. Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System, 2022 and 2035
14.5.1. Lyophilization Services Market for Biopharmaceuticals for Vials, 2022-2035
14.5.2. Lyophilization Services Market for Biopharmaceuticals for Syringes, 2022-2035
14.5.3. Lyophilization Services Market for Biopharmaceuticals for Cartridges, 2022-2035
14.5.4. Lyophilization Services Market for Biopharmaceuticals for Ampoules, 2022-2035
14.5.5. Lyophilization Services Market for Biopharmaceuticals for Other Primary Packaging Systems, 2022-2035
14.6. Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography, 2022 and 2035
14.6.1. Lyophilization Services Market for Biopharmaceuticals in North America, 2022-2035
14.6.2. Lyophilization Services Market for Biopharmaceuticals in Europe, 2022-2035
14.6.3. Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, 2022-2035
14.6.4. Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, 2022-2035
14.6.5. Lyophilization Services Market for Biopharmaceuticals in Latin America, 2022-2035
14.6.6. Lyophilization Services Market for Biopharmaceuticals in Rest of the World, 2022-2035

15. CONCLUDING REMARKS
16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Pharmaceutical International
16.2.1. Company Snapshot
16.2.2. Interview Transcript
16.3. Curia
16.3.1. Company Snapshot
16.3.2. Interview Transcript
16.4. Emergent BioSolutions
16.4.1. Company Snapshot
16.4.2. Interview Transcript
16.5. Liof Pharma
16.5.1. Company Snapshot
16.5.2. Interview Transcript
16.6. Vibalogics
16.6.1. Company Snapshot
16.6.2. Interview Transcript
16.7. Samsung Biologics
16.7.1. Company Snapshot
16.7.2. Interview Transcript
16.8. Bioserv
16.8.1. Company Snapshot
16.8.2. Interview Transcript
16.9. Symbiosis Pharmaceutical Services
16.9.1. Company Snapshot
16.9.2. Interview Transcript
16.10. Patheon
16.10.1. Company Snapshot
16.10.2. Interview Transcript
16.11. Baxter BioPharma Solutions
16.11.1. Company Snapshot
16.11.2. Interview Transcript

17. APPENDIX 1: TABULATED DATA18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Recent Expansions
Figure 2.4 Executive Summary: Survey Analysis
Figure 2.5 Executive Summary: Market Forecast
Figure 3.1 Historical Evolution of Lyophilization
Figure 3.2 Phase Diagram of Water
Figure 3.3 Sublimation of Ice Crystals
Figure 3.4 Key Steps Involved in Formulation and Filling of Biopharmaceuticals
Figure 3.5 Key Components of Lyophilizer
Figure 4.1 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Year of Establishment
Figure 4.2 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Company Size
Figure 4.3 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Location of Headquarters
Figure 4.4 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Scale of Operation
Figure 4.5 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Regulatory Certification / Accreditation
Figure 4.6 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized
Figure 4.7 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Process of Lyophilization
Figure 4.8 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Primary Packaging System
Figure 4.9 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Additional Services Offered
Figure 5.1 Benchmark Analysis: Distribution by Company Size
Figure 5.2 Benchmark Analysis: North America (Peer Group I)
Figure 5.3 Benchmark Analysis: North America (Peer Group II)
Figure 5.4 Benchmark Analysis: North America (Peer Group III)
Figure 5.5 Benchmark Analysis: Europe (Peer Group IV)
Figure 5.6 Benchmark Analysis: Europe (Peer Group V)
Figure 5.7 Benchmark Analysis: Europe (Peer Group VI)
Figure 5.8 Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VII)
Figure 5.9 Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VIII)
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2021
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Most Active Players: Distribution by Number of Partnerships
Figure 9.5 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
Figure 9.6 Partnerships and Collaborations: International and Local Deals
Figure 10.1 Recent Expansions: Cumulative Year-wise Trend, 2018-2021
Figure 10.2 Recent Expansions: Distribution by Type of Expansion
Figure 10.3 Recent Expansions: Distribution by Year and Type of Expansion
Figure 10.4 Recent Expansions: Distribution by Company Size and Location of Headquarters
Figure 10.5 Recent Expansions: Distribution by Location of Expanded Facility
Figure 10.6 Recent Expansions: Distribution by Location of Expanded Facility and Type of Expansion
Figure 10.7 Active Players: Distribution by Number of Recent Expansions
Figure 10.8 Recent Expansions: Distribution by Geography
Figure 11.1 Survey Analysis: Distribution by Geographical Location of Respondents
Figure 11.2 Survey Analysis: Distribution by Seniority Levels of Respondents
Figure 11.3 Survey Analysis: Distribution by Type of Biologic Lyophilized
Figure 11.4 Survey Analysis: Distribution by Type of Primary Packaging System
Figure 11.5 Survey Analysis: Distribution by Scale of Operation
Figure 11.6 Survey Analysis: Distribution by Additional Services Offered
Figure 11.7 Survey Analysis: Distribution by Location of Lyophilization Facility
Figure 11.8 Survey Analysis: Distribution by Share of Lyophilization Operations Outsourced
Figure 11.9 Survey Analysis: Distribution by Likely Current Market Size
Figure 11.10 Survey Analysis: Distribution of Likely Market Share by Type of Biologic Lyophilized
Figure 11.11 Survey Analysis: Distribution of Likely Market Share by Geography
Figure 12.1 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Company Size
Figure 12.2 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Location of Headquarters
Figure 12.3 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Type of Service Offered
Figure 13.1 Key Steps Involved in Spray Drying Process
Figure 14.1 Global Lyophilization Services Market for Biopharmaceuticals, 2022-2035 (USD Billion)
Figure 14.2 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized, 2022 and 2035 (USD Billion)
Figure 14.3 Lyophilization Services Market for Antibodies, 2022-2035 (USD Billion)
Figure 14.4 Lyophilization Services Market for Cell and Gene Therapies, 2022-2035 (USD Billion)
Figure 14.5 Lyophilization Services Market for Vaccines, 2022-2035 (USD Billion)
Figure 14.6 Lyophilization Services Market for Other Biologics, 2022-2035 (USD Billion)
Figure 14.7 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System, 2022 and 2035 (USD Billion)
Figure 14.8 Lyophilization Services Market for Biopharmaceuticals Stored in Vials, 2022-2035 (USD Billion)
Figure 14.9 Lyophilization Services Market for Biopharmaceuticals Stored in Syringes, 2022- 2035 (USD Billion)
Figure 14.10 Lyophilization Services Market for Biopharmaceuticals Stored in Cartridges, 2022-2035 (USD Billion)
Figure 14.11 Lyophilization Services Market for Biopharmaceuticals Stored in Ampoules, 2022-2035 (USD Billion)
Figure 14.12 Lyophilization Services Market for Biopharmaceuticals Stored in Other Primary Packaging Systems, 2022-2035 (USD Billion)
Figure 14.13 Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography, 2022 and 2035 (USD Billion)
Figure 14.14 Lyophilization Services Market for Biopharmaceuticals in North America, 2022- 2035 (USD Billion)
Figure 14.15 Lyophilization Services Market for Biopharmaceuticals in Europe, 2022- 2035 (USD Billion)
Figure 14.16 Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, 2022- 2035 (USD Billion)
Figure 14.17 Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, 2022- 2035 (USD Billion)
Figure 14.18 Lyophilization Services Market for Biopharmaceuticals in Latin America, 2022- 2035 (USD Billion)
Figure 14.19 Lyophilization Services Market for Biopharmaceuticals in Rest of the World, 2022- 2035 (USD Billion)
Figure 15.1 Concluding Remarks: Overall Market Landscape
Figure 15.2 Concluding Remarks: Benchmark Analysis
Figure 15.3 Concluding Remarks: Partnership and Collaborations
Figure 15.4 Concluding Remarks: Recent Expansions
Figure 15.5 Concluding Remarks: Market Forecast

LIST OF TABLES
Table 4.1 List of Lyophilization Service Providers for Biopharmaceuticals
Table 5.1 Benchmark Analysis: Information on Peer Groups
Table 6.1 Leading Lyophilization Service Providers for Biopharmaceuticals in North America
Table 6.2 Baxter BioPharma Solutions: Company Snapshot
Table 6.3 Baxter BioPharma Solutions: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.4 Baxter BioPharma Solutions: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.5 Baxter BioPharma Solutions: Recent Developments and Future Outlook
Table 6.6 Curia: Company Snapshot
Table 6.7 Curia: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.8 Curia: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.9 Curia: Recent Developments and Future Outlook
Table 6.10 Emergent BioSolutions: Company Snapshot
Table 6.11 Emergent BioSolutions: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.12 Emergent BioSolutions: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.13 Emergent BioSolutions: Recent Developments and Future Outlook
Table 6.14 LSNE Contract Manufacturing: Company Snapshot
Table 6.15 LSNE Contract Manufacturing: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.16 LSNE Contract Manufacturing: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.17 LSNE Contract Manufacturing: Recent Developments and Future Outlook
Table 6.18 Lyophilization Technology: Company Snapshot
Table 6.19 Lyophilization Technology: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.20 Lyophilization Technology: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.21 Lyophilization Technology: Recent Developments and Future Outlook
Table 7.1 Leading Lyophilization Service Providers for Biopharmaceuticals in Europe
Table 7.2 CordenPharma: Company Snapshot
Table 7.3 CordenPharma: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.4 CordenPharma: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.5 CordenPharma: Recent Developments and Future Outlook
Table 7.6 Coriolis Pharma: Company Snapshot
Table 7.7 Coriolis Pharma: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.8 Coriolis Pharma: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.9 Coriolis Pharma: Recent Developments and Future Outlook
Table 7.10 Northway Biotech: Company Snapshot
Table 7.11 Northway Biotech: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.12 Northway Biotech: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.13 Northway Biotech: Recent Developments and Future Outlook
Table 7.14 ProJect Pharmaceutics: Company Snapshot
Table 7.15 ProJect Pharmaceutics: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.16 ProJect Pharmaceutics: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.17 Vetter Pharma: Company Snapshot
Table 7.18 Vetter Pharma: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.19 Vetter Pharma: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.20 Vetter Pharma: Recent Developments and Future Outlook
Table 8.1 Leading Lyophilization Service Providers for Biopharmaceuticals in Asia Pacific
Table 8.2 BioZed Engineering: Company Snapshot
Table 8.3 BioZed Engineering: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.4 BioZed Engineering: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.5 BioZed Engineering: Recent Developments and Future Outlook
Table 8.6 CinnaGen: Company Snapshot
Table 8.7 CinnaGen: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.8 CinnaGen: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.9 CinnaGen: Recent Developments and Future Outlook
Table 8.10 MabPlex: Company Snapshot
Table 8.11 MabPlex: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.12 MabPlex: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.13 MabPlex: Recent Developments and Future Outlook
Table 8.14 Samsung Biologics: Company Snapshot
Table 8.15 Samsung Biologics: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.16 Samsung Biologics: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.17 Samsung Biologics: Recent Developments and Future Outlook
Table 8.18 WuXi Biologics: Company Snapshot
Table 8.19 WuXi Biologics: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.20 WuXi Biologics: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.21 WuXi Biologics: Recent Developments and Future Outlook
Table 9.1 Lyophilization Services for Biopharmaceuticals: List of Partnerships and Collaborations, 2018-2021
Table 10.1 Lyophilization Services for Biopharmaceuticals: List of Recent Expansions, 2018-2021
Table 11.1 Lyophilization Services Market for Biopharmaceuticals: List of Respondents
Table 12.1 Lyophilization Cycle Development and Optimization: List of Service Providers
Table 12.2 BSP Pharmaceuticals: Company Snapshot
Table 12.3 CuriRx: Company Snapshot
Table 12.4 GILYOS: Company Snapshot
Table 12.5 Pierre Fabre: Company Snapshot
Table 12.6 Singota Solutions: Company Snapshot
Table 13.1 Spray Drying for Biopharmaceuticals: List of Service Providers
Table 13.2 Comparison of Lyophilization and Spray Drying Process
Table 16.1 Pharmaceutical International: Company Snapshot
Table 16.2 Curia: Company Snapshot
Table 16.3 Emergent BioSolutions: Company Snapshot
Table 16.4 Liof Pharma: Company Snapshot
Table 16.5 Vibalogics: Company Snapshot
Table 16.6 Samsung Biologics: Company Snapshot
Table 16.7 Bioserv: Company Snapshot
Table 16.8 Symbiosis Pharmaceutical Services: Company Snapshot
Table 16.9 Patheon: Company Snapshot
Table 16.10 Baxter BioPharma Solutions: Company Snapshot
Table 17.1 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Year of Establishment
Table 17.2 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Company Size
Table 17.3 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Location of Headquarters
Table 17.4 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Scale of Operation
Table 17.5 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Regulatory Certification / Accreditation
Table 17.6 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized
Table 17.7 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Process of Lyophilization
Table 17.8 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Primary Packaging System
Table 17.9 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Additional Services Offered
Table 17.10 Benchmark Analysis: Asia Pacific and Rest of the World, Peer Group VII
Table 17.11 Benchmark Analysis: Asia Pacific and Rest of the World, Peer Group VIII
Table 17.12 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2021
Table 17.13 Partnerships and Collaborations: Distribution by Type of Partnership
Table 17.14 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 17.15 Most Active Players: Distribution by Number of Partnerships
Table 17.16 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
Table 17.17 Partnerships and Collaborations: International and Local Deals
Table 17.18 Recent Expansions: Cumulative Year-wise Trend, 2018-2021
Table 17.19 Recent Expansions: Distribution by Type of Expansion
Table 17.20 Recent Expansions: Distribution by Year and Type of Expansion
Table 17.21 Recent Expansions: Distribution by Company Size and Location of Headquarters
Table 17.22 Recent Expansions: Distribution by Location of Expanded Facility
Table 17.23 Recent Expansions: Distribution by Location of Expanded Facility and Type of Expansion
Table 17.24 Active Players: Distribution by Number of Recent Expansions
Table 17.25 Recent Expansions: Distribution by Geography
Table 17.26 Survey Analysis: Distribution by Geographical Location of Respondents
Table 17.27 Survey Analysis: Distribution by Seniority Levels of Respondents
Table 17.28 Survey Analysis: Distribution by Type of Biologic Lyophilized
Table 17.29 Survey Analysis: Distribution by Type of Primary Packaging System
Table 17.30 Survey Analysis: Distribution by Scale of Operation
Table 17.31 Survey Analysis: Distribution by Additional Services Offered
Table 17.32 Survey Analysis: Distribution by Location of Lyophilization Facility
Table 17.33 Survey Analysis: Distribution by Share of Lyophilization Operations Outsourced
Table 17.34 Survey Analysis: Distribution by Likely Current Market Size
Table 17.35 Survey Analysis: Distribution of Likely Market Share by Type of Biologic Lyophilized
Table 17.36 Survey Analysis: Distribution Likely Market Share by Geography
Table 17.37 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Company Size
Table 17.38 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Location of Headquarters
Table 17.39 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Type of Service Offered
Table 17.40 Global Lyophilization Services Market for Biopharmaceuticals, 2022-2035 (USD Billion)
Table 17.41 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized, 2022 and 2035 (USD Billion)
Table 17.42 Lyophilization Services Market for Antibodies, 2022-2035 (USD Billion)
Table 17.43 Lyophilization Services Market for Cell and Gene Therapies, 2022-2035 (USD Billion)
Table 17.44 Lyophilization Services Market for Vaccines, 2022-2035 (USD Billion)
Table 17.45 Lyophilization Services Market for Other Biologics, 2022-2035 (USD Billion)
Table 17.46 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System, 2022 and 2035 (USD Billion)
Table 17.47 Lyophilization Services Market for Biopharmaceuticals Stored in Vials, 2022-2035 (USD Billion)
Table 17.48 Lyophilization Services Market for Biopharmaceuticals Stored in Syringes, 2022- 2035 (USD Billion)
Table 17.49 Lyophilization Services Market for Biopharmaceuticals Stored in Cartridges, 2022- 2035 (USD Billion)
Table 17.50 Lyophilization Services Market for Biopharmaceuticals Stored in Ampoules, 2022- 2035 (USD Billion)
Table 17.51 Lyophilization Services Market for Biopharmaceuticals Stored in Other Primary Packaging Systems, 2022- 2035 (USD Billion)
Table 17.52 Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography, 2022 and 2035 (USD Billion)
Table 17.53 Lyophilization Services Market for Biopharmaceuticals in North America, 2022- 2035 (USD Billion)
Table 17.54 Lyophilization Services Market for Biopharmaceuticals in Europe, 2022- 2035 (USD Billion)
Table 17.55 Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, 2022- 2035 (USD Billion)
Table 17.56 Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, 2022- 2035 (USD Billion)
Table 17.57 Lyophilization Services Market for Biopharmaceuticals in Latin America, 2022- 2035 (USD Billion)
Table 17.58 Lyophilization Services Market for Biopharmaceuticals in Rest of the World, 2022- 2035 (USD Billion)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Baxter BioPharma Solutions
  • CordenPharma
  • Coriolis Pharma
  • Curia
  • Emergent BioSolutions
  • LSNE Contract Manufacturing
  • Lyophilization Technology
  • Northway Biotech
  • ProJect Pharmaceutics
  • Vetter Pharma

Methodology

 

 

Loading
LOADING...